Manjit Kooner's journey with Myelodysplastic Syndrome (MDS) has been a challenging one, marked by strength, resilience, and ...

Pediatric bone marrow myelofibrosis (MF) is a rare and complex hematological disorder characterized by cytopenia, bone marrow fibrosis, and systemic ...

Faron Pharmaceuticals Ltd | Company announcement | March 03, 2025 at 14:00:00 EET Inside Information: FDA Grants Orphan Drug Designation for Bexmarilimab in MDS Key highlightsOrphan Drug Designation f ...

PRGN-2012—which Precigen has begun to call by its generic name of zopapogene imadenovec—is a gene therapy designed to elicit immune responses directed against cells infected with human papillomavirus ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Novartis also revealed in its fourth-quarter report that its BTK inhibitor remibrutinib would not be developed in the autoimmune disorder Sjogren’s syndrome, where it had reached phase 2 ...

Nasal Spray Innovation Offers Hope for Traumatic Brain Injury TreatmentA new study led by researchers at Mass General Brigham suggests a nasal ...

Some of the medical conditions that can cause thrombocytopenia include viral or bacterial infections, aplastic anemia, leukemia, and myelodysplastic syndromes ... viral infections, autoimmune ...

A multimodal computational framework for patient stratification and prognosis prediction enables automatic identification of ...

Palak Dave discusses the potential role of artificial intelligence in improving the accuracy of myelodysplastic syndromes ...